ArticleThe Journal of clinical investigation2021

T cell receptor-targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized mice.

Mengyan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.